FDA 483 - Johns Hopkins Hospital Blood Bank - February 13, 2025

An FDA inspection of Johns Hopkins Hospital's Blood Bank/Transfusion Service revealed significant deficiencies in record-keeping and standard operating procedures. The hospital failed to maintain physician signatures for emergency blood product releases and lacked adequate SOPs for compatibility testing and distribution of blood components. These issues indicate a need for improved documentation and procedural controls in critical transfusion processes.